$AHCO

AdaptHealth Corp.

0
1
6

No SEC Form 4 filings for $AHCO in the last 30 days.

High

AdaptHealth Shares Sink After Earnings Miss and Lower Full-Year Guidance

AdaptHealth Corp. (NASDAQ:AHCO) shares fell about 13% premarket after Q2 2026 results missed expectations and the company cut full-year guidance. It reported a net loss of $0.99 per share and revenue of $740.3M versus $848.9M expected. FY revenue guidance was lowered to $2.85B-$2.89B from about $3.49B, with adjusted EBITDA $490M-$520M and free cash flow $80M-$120M.

Stocks making big moves yesterday: AdaptHealth, UL Solutions, Ball, Tidewater, and Wayfair

The article lists five stocks with large Tuesday moves. AdaptHealth (AHCO) fell 39.5% after weaker Q2 results and a major cut to full-year guidance. UL Solutions (ULS) dropped 11.7% on soft Q2 results. Ball (BALL) fell 3.1% despite a revenue beat. Tidewater (TDW) rose 18.5% on mixed Q2 2026 results. Wayfair (W) gained 27.5% after Q2 revenue and earnings beat estimates.

Why AdaptHealth (AHCO) Stock Is Trading Lower Today

AdaptHealth Corp. (AHCO) shares fell about 39.5% after its Q2 results missed expectations and it cut full-year guidance. The company reported a GAAP loss of $0.99 per share versus a $0.15 gain estimate, and revenue of $740.3 million versus $847.2 million expected. It lowered 2026 revenue guidance midpoint to $2.87B from $3.49B and adjusted EBITDA to $490M-$520M, citing West Coast partnership issues and a manufacturer price increase.

AHCO sentiment & insider activity

Over the past 7 days, alphai's AI scored 7 news stories mentioning AHCO (AdaptHealth Corp.). Coverage has skewed bearish: 0 bullish, 1 neutral, and 6 bearish.

Recent AHCO coverage spans earnings, market movers and mergers & acquisitions.

What's driving AHCO

  • Guidance reset and margin pressure raise downside risk to 2026 estimates and near-term cash-flow expectations.

    yahoo.com · Aug 6, 2026

  • Guidance cut after weak Q2 is likely to pressure near-term estimates and sentiment.

    stockstory.org · Aug 5, 2026

  • The guidance cut and profitability miss are likely to drive further de-rating until investors see West Coast partnership stabilization and pricing normalization.

    financialcontent.com · Aug 4, 2026

  • The earnings/guidance miss and GAAP loss print likely drive near-term downside risk and raise questions about margin and demand trajectory.

    financialcontent.com · Aug 4, 2026

  • The selloff is driven by a profitability miss plus uncertainty around full-year outlook and labor-cost persistence, with the Diabetes Health segment sale reclassified as discontinued operations.

    investing.com · Aug 4, 2026

alphai scores every news story that mentions AHCO with an AI model for sentiment and relevance, and aggregates insider trades from AdaptHealth Corp.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $AHCO

Score
$AHCOHighAI 9/10

AdaptHealth Shares Sink After Earnings Miss and Lower Full-Year Guidance

AdaptHealth Corp. (NASDAQ:AHCO) shares fell about 13% premarket after Q2 2026 results missed expectations and the company cut full-year guidance. It reported a net loss of $0.99 per share and revenue of $740.3M versus $848.9M expected. FY revenue guidance was lowered to $2.85B-$2.89B from about $3.49B, with adjusted EBITDA $490M-$520M and free cash flow $80M-$120M.

Stocks making big moves yesterday: AdaptHealth, UL Solutions, Ball, Tidewater, and Wayfair

The article lists five stocks with large Tuesday moves. AdaptHealth (AHCO) fell 39.5% after weaker Q2 results and a major cut to full-year guidance. UL Solutions (ULS) dropped 11.7% on soft Q2 results. Ball (BALL) fell 3.1% despite a revenue beat. Tidewater (TDW) rose 18.5% on mixed Q2 2026 results. Wayfair (W) gained 27.5% after Q2 revenue and earnings beat estimates.

$AHCOHighAI 9/10

Why AdaptHealth (AHCO) Stock Is Trading Lower Today

AdaptHealth Corp. (AHCO) shares fell about 39.5% after its Q2 results missed expectations and it cut full-year guidance. The company reported a GAAP loss of $0.99 per share versus a $0.15 gain estimate, and revenue of $740.3 million versus $847.2 million expected. It lowered 2026 revenue guidance midpoint to $2.87B from $3.49B and adjusted EBITDA to $490M-$520M, citing West Coast partnership issues and a manufacturer price increase.

$AHCOMedAI 8/10

Why is AdaptHealth stock plummeting today?

AdaptHealth (AHCO) shares fell about 22% in pre-open after it reported Q2 2026 results. Analysts expected EPS of $0.15–$0.18 on revenue near $849M. The company has posted GAAP losses of $0.12 in Q1 2026 and $0.76 in Q4 2025. It also agreed to sell its Diabetes Health segment to Cardinal Health for $235M, with guidance to be addressed on the earnings call.

$AHCOHigh

AdaptHealth Corp. (AHCO): Results of Operations and Financial Condition

AdaptHealth Corp. (AHCO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ahco-20260804x8k_ex991.htm EX-99.1 Document Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2026 RESULTS CONSHOHOCKEN, Pa. – August 4, 2026 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”) , a national leader in providing

$AHCOMed

AdaptHealth (AHCO) Reports Earnings Tomorrow: What To Expect

AdaptHealth Corp. (NASDAQ:AHCO) will report earnings Tuesday before market open. The prior quarter showed revenue of $819.8 million, up 5.4% year over year, beating revenue estimates but missing EPS expectations. For the upcoming quarter, analysts expect revenue growth of 5.9% and have largely held estimates steady. The average analyst price target is $14.14 vs $10.80.

$CAHMedAI 9/10

Cardinal Health to buy AdaptHealth diabetes unit, Strive Medical for $360 million By Reuters

Cardinal Health (CAH) agreed to buy AdaptHealth’s diabetes health business for $235 million cash and to acquire Strive Medical in a separate deal, for about $360 million total, to expand its at-Home Solutions and diabetes care. Cardinal said the deals should add to adjusted EPS within 12 months after closing. AdaptHealth and Strive Medical described their diabetes and urology-focused services.

$AHCOMed

AdaptHealth Corp. (AHCO): Entry into a Material Definitive Agreement

AdaptHealth Corp. (AHCO) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-2.1 2 tm2620877d1_ex2-1.htm EXHIBIT 2.1 Exhibit 2.1 EXECUTION VERSION CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD LIKELY

Med

AdaptHealth discloses June cyberattack resulting in patient data exposure

AdaptHealth disclosed in a July 2 SEC Form 8-K that a June 15 cyberattack led to data exfiltration from its cloud applications. The company said patient data and PHI, including stored password files tied to insurance billing, were exposed, but no Social Security numbers or payment card/account data were compromised. It attributed the breach to social engineering of a contractor session and says the incident is contained while investigations continue.

Related tickers